Effects of antidepressants on the production of cytokines
- PMID: 12466038
- DOI: 10.1017/S1461145702003164
Effects of antidepressants on the production of cytokines
Abstract
There is now evidence that major depression is associated with an up-regulation of the inflammatory response system (IRS). One of the major factors in this IRS activation is the hyperproduction of pro-inflammatory cytokines. Recently, a number of studies examined whether there is a causative role of these inflammatory mediators in the aetiology of major depression. Studies with animal models and cytokine immune therapy in humans suggest that pro-inflammatory cytokines induce depressive symptomatology. Moreover, these depressive symptoms can be effectively reversed by antidepressant treatment. Thus, it may be suggested that antidepressants suppress pro-inflammatory cytokine production and/or action, resulting in improvement of depressive symptoms. The influence of antidepressants on cytokine production has been examined in culture systems in vitro, and in animal models of depression - in which cytokine production is induced by endotoxin administration. Results suggest that antidepressants of several classes decrease the production of pro-inflammatory cytokines such as interferon-gamma and tumour necrosis factor-alpha, and increase that of interleukin-10, an anti-inflammatory cytokine. Further, the effect of antidepressive treatment on cytokine secretion and on plasma levels of cytokines in depressed patients has been studied. Unfortunately, different approaches to examine cytokine production and different techniques to measure cytokines in plasma are used in these studies. Despite this, current data indicate a normalization of cytokine plasma levels and cytokine production after antidepressant treatment. It is clear, however, that more research is warranted and we strongly argue the need for higher standardization in the methodology used to examine the cytokine network in depressed patients.
Similar articles
-
[Antidepressants and cytokines--clinical and experimental studies].Psychiatr Pol. 2005 Sep-Oct;39(5):921-36. Psychiatr Pol. 2005. PMID: 16358592 Review. Polish.
-
Cytokines as biomarkers in depressive disorder: current standing and prospects.Int Rev Psychiatry. 2013 Oct;25(5):592-603. doi: 10.3109/09540261.2013.813442. Int Rev Psychiatry. 2013. PMID: 24151804 Review.
-
Cytokines: abnormalities in major depression and implications for pharmacological treatment.Hum Psychopharmacol. 2004 Aug;19(6):397-403. doi: 10.1002/hup.609. Hum Psychopharmacol. 2004. PMID: 15303243 Review.
-
Cytokines and glucocorticoid receptors are associated with the antidepressant-like effect of alarin.Peptides. 2016 Feb;76:115-29. doi: 10.1016/j.peptides.2016.01.002. Epub 2016 Jan 15. Peptides. 2016. PMID: 26779986
-
Cytokines as mediators of depression: what can we learn from animal studies?Neurosci Biobehav Rev. 2005;29(4-5):891-909. doi: 10.1016/j.neubiorev.2005.03.023. Neurosci Biobehav Rev. 2005. PMID: 15885777 Review.
Cited by
-
Systematic metabolic characterization of mental disorders reveals age-related metabolic disturbances as potential risk factors for depression in older adults.MedComm (2020). 2022 Sep 30;3(4):e165. doi: 10.1002/mco2.165. eCollection 2022 Dec. MedComm (2020). 2022. PMID: 36204590 Free PMC article.
-
Living well with medical comorbidities: a biopsychosocial perspective.J Gerontol B Psychol Sci Soc Sci. 2012 Sep;67(5):535-44. doi: 10.1093/geronb/gbr152. Epub 2012 Feb 29. J Gerontol B Psychol Sci Soc Sci. 2012. PMID: 22377799 Free PMC article.
-
Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile.BMC Med. 2013 May 15;11:129. doi: 10.1186/1741-7015-11-129. BMC Med. 2013. PMID: 23672628 Free PMC article. Review.
-
Cytokines and glucocorticoid receptor signaling. Relevance to major depression.Ann N Y Acad Sci. 2009 Oct;1179:86-105. doi: 10.1111/j.1749-6632.2009.04984.x. Ann N Y Acad Sci. 2009. PMID: 19906234 Free PMC article. Review.
-
Socioeconomic and psychosocial predictors of interleukin-6 in the MIDUS national sample.Health Psychol. 2010 Nov;29(6):626-35. doi: 10.1037/a0021360. Health Psychol. 2010. PMID: 20954777 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical